Official site

(888-730-7056)

The 2008 BD Boston Conference is sponsored by Alexandria Real Estate Equities, Inc., Pfizer Inc., Biogen Idec, Longwood Venture Partners, and Roche Pharmaceuticals.

This is an invitation only event, please contact general@bostonbiotechconference.com for details.

Hosts:

Richard Aldrich - Chairman, RA Capital
Richard Douglas - SVP of Corporate Development, Genzyme
Jeremy Goldberg - CEO, Endo Pharmaceuticals
Ed Harrigan - SVP, Worldwide Business Development, Pfizer Inc.
Steve Krognes - Head of M&A, F. Hoffmann-La Roche Ltd.
Sandy Macrae - Vice President, Business Development, GSK
Adelene Perkins - Chief Business Officer, Infinity Pharmaceuticals, Inc.
Kerry Reinertsen - VP of Corporate and Business Development, Vertex
Alain Vertes - Global Alliance Director, F. Hoffmann-La Roche Ltd.
Christoph Westphal - CEO, Sirtris Pharmaceuticals
Mark Wiggins - Executive VP of Corporate and Business Development, Biogen Idec

Agenda:

8:00- 8:30 am Networking Breakfast
8:30- 9:15 am Pharma Panel (Panelists: Steve Krognes, Alain Vertes, Ed Harrigan, Sandy Macrae, Barry Greene, Jeremy Goldberg)
9:15- 9:45 am VC/Investor Panel (Panelists: Richard Aldrich, John Clarke, Douglas Fambrough, Stephen Hoffman, Kevin Starr, Jeff Leiden)
9:45- 10:30 am Biotech Panel (Panelists: Adelene Perkins, Safi Bachall, Jeff Williams, Mark Wiggins, Kerry Reinertsen, Richard Douglas)
10:30-11:15 am Networking Break
11:15- 11:45 am Keynote - Edmund P. Harrigan: SVP, Worldwide Business Development, Pfizer Inc.
11:45-12:30 pm Networking Lunch